Sep 9, 2026 07:00AM
Sep 8, 2026 07:00AM
Jul 20, 2026 07:00AM
Jul 20, 2026 07:00AM
Jul 13, 2026 06:40AM
Jul 8, 2026 07:00AM
Jul 8, 2026 07:00AM OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
May 19, 2026 07:00AM
May 19, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 7, 2026 09:43AM
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
Mar 18, 2026 07:00AM
Mar 18, 2026 07:00AM
Feb 23, 2026 11:00AM
Feb 10, 2026 08:00AM
Feb 10, 2026 08:00AM
Jan 30, 2026 11:30AM
Jan 30, 2026 11:30AM OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
Jan 29, 2026 06:52AM
Jan 28, 2026 07:40AM
Jan 28, 2026 07:40AM
Jan 26, 2026 06:50AM
Jan 23, 2026 07:00AM
Jan 23, 2026 07:00AM
Jan 5, 2026 07:00AM OKYO Pharma names Robert Dempsey as CEO
Jan 5, 2026 07:00AM
Dec 19, 2025 07:00AM
Dec 15, 2025 08:33AM
Dec 15, 2025 08:30AM
Dec 11, 2025 08:30AM
Dec 11, 2025 08:30AM
Dec 7, 2025 11:48PM B.Riley Starts OKYO Pharma Ltd. (OKYO) at Buy
Dec 3, 2025 07:01AM
Dec 3, 2025 07:00AM
Nov 21, 2025 08:30AM
Nov 21, 2025 08:30AM
Nov 18, 2025 08:30AM
Oct 29, 2025 07:00AM
Oct 16, 2025 08:30AM OKYO Pharma chairman acquires 210,000 shares
Oct 16, 2025 08:30AM
Sep 23, 2025 06:39AM
Sep 22, 2025 08:35AM
Sep 22, 2025 08:30AM
Jul 17, 2025 09:00AM
Jul 17, 2025 09:00AM
Jul 17, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
Jul 16, 2025 09:21AM

330,739 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All